Deamino Arginine Vasopressin
"Deamino Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
Descriptor ID |
D003894
|
MeSH Number(s) |
D06.472.699.631.692.781.100.250 D12.644.400.900.100.250 D12.644.456.925.100.250 D12.644.548.691.692.781.100.250 D12.776.631.650.937.100.250
|
Concept/Terms |
Deamino Arginine Vasopressin- Deamino Arginine Vasopressin
- Arginine Vasopressin, Deamino
- 1-Desamino-8-arginine Vasopressin
- Vasopressin, 1-Desamino-8-arginine
- Desmopressin
- Vasopressin, Deamino Arginine
- 1-Deamino-8-D-arginine Vasopressin
- Vasopressin, 1-Deamino-8-D-arginine
DDAVP- DDAVP
- Octostim
- Desmotabs
- Octim
- Desmopressine Ferring
- Ferring, Desmopressine
- Desmospray
Desmopressin Acetate- Desmopressin Acetate
- Acetate, Desmopressin
- Desmopressin Monoacetate, Trihydrate
- Monoacetate, Trihydrate Desmopressin
- Trihydrate Desmopressin Monoacetate
|
Below are MeSH descriptors whose meaning is more general than "Deamino Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Deamino Arginine Vasopressin".
This graph shows the total number of publications written about "Deamino Arginine Vasopressin" by people in this website by year, and whether "Deamino Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deamino Arginine Vasopressin" by people in Profiles.
-
Mahboobi SK. Heyde's syndrome and postoperative bleeding after aortic valve replacement - Is there a role for prophylactic desmopressin? J Clin Anesth. 2019 Sep; 56:142.
-
Gurwitz JH. Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased Vigilance. J Am Geriatr Soc. 2018 11; 66(11):2045-2047.
-
Berkenwald A, Pires J, Ellsworth P. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis. J Pediatr Urol. 2016 Aug; 12(4):220.e1-6.
-
Ellsworth PI. Response to Commentary re 'Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis'. J Pediatr Urol. 2016 Aug; 12(4):222.
-
Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, Dupont WD, Robertson D, Raj SR. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012 Sep; 9(9):1484-90.